Correlation Between Valneva SE and Rani Therapeutics
Can any of the company-specific risk be diversified away by investing in both Valneva SE and Rani Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Valneva SE and Rani Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Valneva SE ADR and Rani Therapeutics Holdings, you can compare the effects of market volatilities on Valneva SE and Rani Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Valneva SE with a short position of Rani Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Valneva SE and Rani Therapeutics.
Diversification Opportunities for Valneva SE and Rani Therapeutics
0.66 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Valneva and Rani is 0.66. Overlapping area represents the amount of risk that can be diversified away by holding Valneva SE ADR and Rani Therapeutics Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rani Therapeutics and Valneva SE is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Valneva SE ADR are associated (or correlated) with Rani Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rani Therapeutics has no effect on the direction of Valneva SE i.e., Valneva SE and Rani Therapeutics go up and down completely randomly.
Pair Corralation between Valneva SE and Rani Therapeutics
Given the investment horizon of 90 days Valneva SE ADR is expected to under-perform the Rani Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Valneva SE ADR is 1.64 times less risky than Rani Therapeutics. The stock trades about -0.05 of its potential returns per unit of risk. The Rani Therapeutics Holdings is currently generating about -0.02 of returns per unit of risk over similar time horizon. If you would invest 797.00 in Rani Therapeutics Holdings on August 30, 2024 and sell it today you would lose (598.00) from holding Rani Therapeutics Holdings or give up 75.03% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Valneva SE ADR vs. Rani Therapeutics Holdings
Performance |
| Timeline |
| Valneva SE ADR |
| Rani Therapeutics |
Valneva SE and Rani Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Valneva SE and Rani Therapeutics
The main advantage of trading using opposite Valneva SE and Rani Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Valneva SE position performs unexpectedly, Rani Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rani Therapeutics will offset losses from the drop in Rani Therapeutics' long position.| Valneva SE vs. Ikena Oncology | Valneva SE vs. Eliem Therapeutics | Valneva SE vs. HCW Biologics | Valneva SE vs. RenovoRx |
| Rani Therapeutics vs. Ikena Oncology | Rani Therapeutics vs. Eliem Therapeutics | Rani Therapeutics vs. HCW Biologics | Rani Therapeutics vs. RenovoRx |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Complementary Tools
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |